Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1729427 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $4.85Day −3.00%Mkt cap $7M1Y −36.4%Off 52W high −54.2%Vol (1Y) 259.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,684 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest1.1% of sh out |
| Days to cover1.7d |
| 13F net flow (QoQ)+0.84% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$16.5M |
| ROE−296.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−7.6% |
| 1Y−36.4% |
| 3Y−100.0% |
| 5Y−100.0% |
| Since incept. (ann.)−86.9% |
Price return through 2026-07-30 · series begins 2019-11-08. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)259.0% |
| Ann. volatility (3Y)191.5% |
| Sharpe (1Y)0.42 |
| Sharpe (3Y)−0.96 |
| Max drawdown (1Y)−79.8% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)2.49 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Stonepine Capital Management, LLC | 61,000 | $145,790 | 7.52% | +24.9% |
| Ikarian Capital, LLC | 45,830 | $109,992 | 5.65% | +0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 23,189 | $55,653 | 2.86% | new |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,524 | $32,322 | 1.67% | +0.0% |
| Tower Research Capital LLC (TRC) | 1,310 | $3,131 | 0.16% | new |
| UBS Group AG | 729 | $1,742 | 0.09% | +19.3% |
| Sound Income Strategies, LLC | 16 | $36 | 0.00% | +0.0% |
| BARRETT & COMPANY, INC. | 8 | $19 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$7.30 | — | — | — |
| 2025-09-30 | 2025-11-14 | −$5.76 | — | — | — |
| 2025-06-30 | 2025-08-14 | — | — | — | — |
| 2025-03-31 | 2025-05-15 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
